The INSPIRE Program is a PFIZER-initiated patient assistance program that aims to help cancer patients gain access to Pfizer Oncology medicines.
Patients enrolled in the program will have access to medical education, coaching on possible sources of financial support for cancer treatment, and free goods. Currently, the program has Crizotinib (Xalkori). And soon, other Oncology products will also be included.
Patients enrolled in the INSPIRE Program are entitled to 1 free capsule of Crizotinib (Xalkori) for every capsule of Crizotinib (Xalkori) that they will purchase out of pocket.
In addition, patients enrolled in INSPIRE are entitled to a capping program. This means that after they have completed taking 730 capsules of Crizotinib (Xalkori) (equivalent to 1 year of treatment), they will be entitled to 5 years of Crizotinib (Xalkori) for free provided that the patient continues to benefit from the treatment and to be prescribed by his/her medical oncologist.
Capsules purchased out of pocket or through guarantee letters from the Philippine Charity Sweepstakes Office (PCSO) or other funding agencies will all be counted towards the patient’s eligibility for the capping program.